Study Reveals Pfizer-BioNTech Vaccine Less Effective Against South African Variant
Moderna reveals similar results of its two-dose vaccine against B.1.35.1 variant
Full Article
Study Reveals Pfizer-BioNTech Vaccine Less Effective Against South African Variant
VOA News
0 shares
3 views
You might like
Related news coverage
Pfizer-BioNTech's new trial to test COVID-19 vaccine booster against South African variant
Zee News
Pfizer Inc and BioNTech SE are in talks with regulatory authorities about testing a vaccine modified to protect specifically..
-
FDA says J&J 1-dose shot prevents COVID; final decision soon
SeattlePI.com
-
FDA says J&J 1-dose shot prevents COVID; final decision soon
SeattlePI.com
-
Pfizer says variant identified in South Africa could significantly reduce protective antibodies from vaccine
CBC.ca
-
South African variant could significantly reduce Pfizer vaccine protection, study suggests
Telegraph.co.uk
Advertisement
More coverage
Pfizer: South African variant could significantly reduce vaccine protection
Jerusalem Post
It is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
-
Pfizer says South African variant could significantly reduce vaccine protection
Haaretz
-
Pfizer/BioNTech vaccine weaker against South African variant, study says; New York City could run out of doses. Latest COVID-19 updates
Upworthy
-
Pfizer says variant first found in South Africa could significantly reduce vaccine protection
CTV News
-
BioNTech/Pfizer vaccine is less potent against South African variant
FT.com